CAPRICOR THERAPEUTICS, INC. (CAPR) — research page
US · us-cm-kg/NASDAQ/CAPR · as of 2026-11-08
Identity and listing
The issuer is CAPRICOR THERAPEUTICS, INC., listed on NASDAQ under ticker CAPR, with ISIN US14070B3096 and LEI 5493002ZI5PDLXV4DX14. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | CAPRICOR THERAPEUTICS, INC. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CAPR | source · 2026-11-08 |
| ISIN | US14070B3096 | source · 2026-11-08 |
| LEI | 5493002ZI5PDLXV4DX14 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 67 filings in the twelve months to 2026-11-08, on 41 filing days. The median gap between filing days is 5.0 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is a regulatory filing dated 2026-10-14, 25 days before the record date, against a NASDAQ median latency of 5.0 days and a sector median of 4.0 days. The filings comprise 26 directors' dealings, 17 regulatory filings, 10 corporate news, 8 results, 3 prospectuses and 3 AGM/EGM notices.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 67 | 5 | 25 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-14 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-09-14 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-08-24 | corporate_news | 8-K | 8-K — 8-K (items 8.01,9.01) |
| 2026-08-19 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-08-14 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Rose, Snyder & Jacobs LLP, located in Encino, California. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 10 research houses: B. Riley Securities, Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc., Cantor Fitzgerald & Co., Maxim Group, JonesTrading, ROTH Capital Partners, H.C. Wainwright & Co., Piper Sandler & Co., and A.G.P. / Alliance Global Partners.
| research house | analyst | source · read date |
|---|---|---|
| B. Riley Securities | Madison El-Saadi, Ph.D. | issuer page · 2026-11-11 |
| Oppenheimer & Co. Inc. | Leland Gershell, M.D., Ph.D. | issuer page · 2026-11-11 |
| Ladenburg Thalmann & Co. Inc. | Rick Bienkowski, Ph.D. | issuer page · 2026-11-11 |
| Cantor Fitzgerald & Co. | Kristen Kluska | issuer page · 2026-11-11 |
| Maxim Group | Jason McCarthy, Ph.D. | issuer page · 2026-11-11 |
| JonesTrading | Catherine Novack | issuer page · 2026-11-11 |
| ROTH Capital Partners | Boobalan Pachaiyappan, Ph.D. | issuer page · 2026-11-11 |
| H.C. Wainwright & Co. | Joseph Pantginis, Ph.D. | issuer page · 2026-11-11 |
| Piper Sandler & Co. | Edward A. Tenthoff | issuer page · 2026-11-11 |
| A.G.P. / Alliance Global Partners | Matthew Venezia | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. The market's vintage is sealed.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001133869.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/CAPR (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1133869/000110465926029580/capr-20251231x10k.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://www.capricor.com/investors/stock-data/analyst-coverage (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NASDAQ/CAPR (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US14070B3096"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:d8a5ccc27d7ce62f.